| 1. |
Jeon S, Lee WK, Lee Y, et al. Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation[J]. Ophthalmology, 2012, 119(9): 1892-1898. DOI: 10.1016/j.ophtha.2012.03.032.
|
| 2. |
Shapira Y, Mimouni M, Vishnevskia-Dai V. Cytomegalovirus retinitis in HIV-negative patients-associated conditions, clinical presentation, diagnostic methods and treatment strategy [J/OL]. Acta Ophthalmol, 2017, 2017:E1[2017-10-25]. https://doi.org/10.1111/aos.13553. DOI: 10.1111/aos.13553. [published online ahead of print].
|
| 3. |
Pathanapitoon K, Tesavibul N, Choopong P, et al. Clinical manifestations of cytomegalovirus-associated posterior uveitis and panuveitis in patients without human immunodeficiency virus infection [J]. JAMA Ophthalmol, 2013, 131(5): 638-645. DOI: 10.1001/jamaophthalmol.2013.2860.
|
| 4. |
Iu LP, Fan MC, Lau JK, et al. Long-term follow-up of cytomegalovirus retinitis in non-HIV immunocompromised patients: clinical features and visual prognosis[J]. Am J Ophthalmol, 2016, 165: 145-153. DOI: 10.1016/j.ajo.2016.03.015.
|
| 5. |
Vishnevskia-Dai V, Shapira Y, Rahav G, et al. Cytomegalovirus retinitis in HIV-negative patients: a practical management approach [J]. Ophthalmology, 2015, 122(4): 866-868. DOI: 10.1016/j.ophtha.2014.11.010.
|
